Pembrolizumab and Interferon Gamma-1b in Treating Patients With Stage IB-IVB Relapsed or Refractory Mycosis Fungoides and Sezary Syndrome
Conditions:   Recurrent Mycosis Fungoides and Sezary Syndrome;   Refractory Mycosis Fungoides;   Stage IB Mycosis Fungoides and Sezary Syndrome;   Stage II Mycosis Fungoides and Sezary Syndrome;   Stage IIA Mycosis Fungoides and Sezary Syndrome;   Stage IIB Mycosis Fungoides  and Sezary Syndrome;   Stage III Mycosis Fungoides and Sezary Syndrome;   Stage IIIA Mycosis Fungoides and Sezary Syndrome;   Stage IIIB Mycosis Fungoides and Sezary Syndrome;   Stage IV Mycosis Fungoides and Sezary Syndrome;   Stage IVA Mycosis Fungoides and Seza ry Syndrome;   ...
Source: ClinicalTrials.gov - February 22, 2017 Category: Research Source Type: clinical trials

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
< b > Conditions < /b > :   Mycosis Fungoides;   Non-Hodgkin's Lymphoma < br/ > < b > Intervention < /b > :   < br/ > < b > Sponsor < /b > :   Stanford University < br/ > < b > Not yet recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials